Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology

被引:1
作者
Moylan, Elizabeth C. [1 ]
Morrey, Christopher [1 ]
Appleford-Cook, Joanne M. [1 ]
机构
[1] BioMed Cent Ltd, London WC1X 8HL, England
关键词
D O I
10.1186/2050-6511-13-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experimental and clinical pharmacology including clinical trials. In this editorial we discuss the origins of this new journal and the ethos and policies under which it will operate.
引用
收藏
页数:3
相关论文
共 16 条
[1]  
APPLEFORDCOOK J, REJECT NOT REJECT IS
[2]  
APPLEFORDCOOK J, BMC SERIES J SECTION
[3]   An interview with Philip Biggin, Section Editor for Computational, in silico and modelling studies [J].
Biggin, Philip C. .
BMC PHARMACOLOGY & TOXICOLOGY, 2012, 13
[4]  
*BIOMED CENTR, BMC SER J PEER REV P
[5]   Strengthen and stabilize the FDA [J].
Carpenter, Daniel .
NATURE, 2012, 485 (7397) :169-170
[6]   Making reviewers visible - Openness, accountability, and credit [J].
Godlee, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21) :2762-2765
[7]   Open science and reproducible research New reports call for scientists to share data and publishers to embrace open access [J].
Groves, Trish ;
Godlee, Fiona .
BRITISH MEDICAL JOURNAL, 2012, 344
[8]   Is open peer review the fairest system? Yes [J].
Groves, Trish .
BRITISH MEDICAL JOURNAL, 2010, 341
[9]   The potential for selective pharmacological therapies through biased receptor signaling [J].
Kenakin, Terry .
BMC PHARMACOLOGY & TOXICOLOGY, 2012, 13
[10]   Is open peer review the fairest system? No [J].
Khan, Karim .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341